share_log

藥明康德：海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Apr 1 07:30
Summary by Moomoo AI
药明康德於2024年第一季度實施了2019年限制性股票與股票期權激勵計劃的首次授予股票期權自主行權，共有311名激勵對象參與，其中225,894股股票期權已完成過戶登記，占本次可行權總量的13.36%。截至2024年3月31日，累計行權且完成股份過戶登記的股票期權數量為1,466,331股，占本次可行權總量的86.72%。行權所得股票於行權日後的第一個交易日到達股票賬戶，並於第二個交易日上市交易。本次行權募集資金人民幣8,724,026.28元，將用於補充公司流動資金。本次行權對公司財務狀況和經營成果不構成重大影響。董事會於2024年4月2日發布公告。
药明康德於2024年第一季度實施了2019年限制性股票與股票期權激勵計劃的首次授予股票期權自主行權，共有311名激勵對象參與，其中225,894股股票期權已完成過戶登記，占本次可行權總量的13.36%。截至2024年3月31日，累計行權且完成股份過戶登記的股票期權數量為1,466,331股，占本次可行權總量的86.72%。行權所得股票於行權日後的第一個交易日到達股票賬戶，並於第二個交易日上市交易。本次行權募集資金人民幣8,724,026.28元，將用於補充公司流動資金。本次行權對公司財務狀況和經營成果不構成重大影響。董事會於2024年4月2日發布公告。
In the first quarter of 2024, Ming Kund implemented the first grant of equity option autonomy under the 2019 Restricted Stock and Stock Option Incentive Program. A total of 311 incentive participants participated, of which 225,894 share options were successfully registered, representing 13.36% of the total number of options available this time. As of March 31, 2024, the number of stock options accrued and completed share overdraft registration was 1,466,331 shares, representing 86.72% of the total exercisable amount at this time. The authorized shares arrive in the stock account on the first trading day after the exercise date and are listed on the second trading day. This equity raising of RMB8,724,026.28 will be used to supplement the Company's liquidity. This exercise does not have a significant impact on the financial condition and operating results of the Company. The Board of Directors issued a notice on 2 April 2024.
In the first quarter of 2024, Ming Kund implemented the first grant of equity option autonomy under the 2019 Restricted Stock and Stock Option Incentive Program. A total of 311 incentive participants participated, of which 225,894 share options were successfully registered, representing 13.36% of the total number of options available this time. As of March 31, 2024, the number of stock options accrued and completed share overdraft registration was 1,466,331 shares, representing 86.72% of the total exercisable amount at this time. The authorized shares arrive in the stock account on the first trading day after the exercise date and are listed on the second trading day. This equity raising of RMB8,724,026.28 will be used to supplement the Company's liquidity. This exercise does not have a significant impact on the financial condition and operating results of the Company. The Board of Directors issued a notice on 2 April 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more